title: Outcome of thyroid associated ophthalmopathy treated by radiation therapy.
abstract: Thyroid associated orbitopathy is a common manifestation of Graves disease. Many options can be considered for treatment. In this case series, we reviewed the medical records of 17 patients who received radiation therapy (RT) for GO in a tertiary care center between 1997 and 2007. All patients received 20 Gy to both orbits and 12 of them (71%) had already received one or more trials of steroid therapy prior to RT. After a median follow-up of 2 years, a subjective improvement in exophthalmos and vision was reported by all patients at the end of RT but only 3 patients reported a decrease in their diplopia immediately after therapy. Symptoms continued to improve with time in many patients: 22% had complete reversal of their symptoms and signs, and the remaining 78% had partial improvement. Two patients developed recurrent signs and symptoms, both of them were smokers who continued to smoke after treatment. About 60-65% of patients responded favorably to RT alone which increased to 87-97% when RT is combined with steroids. No patients developed late toxicity during the follow-up period. We conclude that RT is an effective treatment option in GO even in patients who failed previous treatment with steroids or surgical decompression. Based on our own clinical experiences and the literature data, the combination of RT and intravenous corticosteroid administration may improve the response rate.
authors.affiliation: Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. mrnabboud9@gmail.com
authors.forename: Mirna
authors.initials: M
authors.lastname: Abboud
authors.forename: Asma
authors.initials: A
authors.lastname: Arabi
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Salti
authors.forename: Fady
authors.initials: F
authors.lastname: Geara
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D049970:Graves Ophthalmopathy / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008877:Middle East; D012008:Recurrence; D012189:Retrospective Studies; D012907:Smoking; D013256:Steroids / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000188:drug therapy* / Q000532:radiotherapy*; D016896:Treatment Outcome
chemical_list: D013256:Steroids